Stents

Medtronic, CE Mark, Resolute Onyx DES, drug-eluting stent, expanded sizes and indications
News | Stents Drug Eluting | February 02, 2016

February 2, 2016 — Medtronic plc announced the recent CE Mark and commercial launch for an expanded size matrix of...

TOBA-BTK study, six-month results, LINC 2016, Tack Endovascular System
News | Peripheral Artery Disease (PAD) | January 29, 2016

January 29, 2016 — Intact Vascular Inc. announced that positive six-month results from its Tack Optimized Balloon...

Blog | January 20, 2016

At the beginning of each year, I always try to determine what the next big cardiovascular technology advances to...

Abbott, Absorb, BVS, FDA review, FDA panel

The Abbott Absorb BVS.

News | Cath Lab | January 20, 2016 | Dave Fornell

The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel is set to review data and offer...

News | Stents Drug Eluting | January 08, 2016

January 8, 2016 — In December, Stentys announced completion of patient enrollment in DESSOLVE III. The 1,400-patient...

Biotronik Astron stent
Technology | Stents Peripheral | December 31, 2015

December 31, 2015 - The U.S. Food and Drug Administration (FDA) has cleared Biotronik's Astron Peripheral Self-...

Technology | Stents Bare Metal | December 09, 2015

December 9, 2015 — Medinol U.S. recently opened their commercial business in Parsippany, New Jersey, followed by the...

Blog | Cath Lab | November 05, 2015

For the past few years, the focus of the annual Transcatheter Cardiovascular Therapeutics (TCT) meetings has been on...

Videos | TCT | November 05, 2015

DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies...

Videos | TCT | November 05, 2015

Tom Watson, clinical analyst for MDBuyLine, and DAIC Dave Fornell discuss some of the technology trends at the 2015...

News | Stents Bioresorbable | October 30, 2015

October 30, 2015 — Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable...

Videos | Stents Drug Eluting | October 30, 2015

Dr. Stephen Worthley, Ph.D., director of the cardiac cath labs at Royal Adelaide Hospital at the University of...

Videos | Stents Bioresorbable | October 30, 2015

Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for...

News | Stents Drug Eluting | October 27, 2015

October 27, 2015 — Results from the multicenter, prospective, randomized PANDA III trial indicate that the BuMA...

REMEDEE Registry, one-year outcomes, Combo dual therapy stent, OrbusNeich, TCT 2015
News | Stents Drug Eluting | October 26, 2015

October 26, 2015 — OrbusNeich announced the presentation of the one-year clinical outcomes from the 1,000-patient...

Overlay Init